INSIST! Chronic Lymphocytic Leukemia
July 2021
Biomarker testing in Chronic Lymphocytic Leukemia (CLL) is essential to ensure patients are receiving the best, most personalized care available. The goal of INSIST! CLL is to educate and empower patients and care partners to speak up and insist on better care.
Program topics include:
Personalize Your Experience!
Create an account to save items and receive information curated just for you.
Understanding CLL Testing
CLL Treatment Decisions
This program is supported by AbbVie, Janssen, and Pharmacyclics, and through generous donations from people like you.
